The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,330.00
Bid: 1,328.00
Ask: 1,332.00
Change: 20.00 (1.53%)
Spread: 4.00 (0.301%)
Open: 1,318.00
High: 1,346.00
Low: 1,298.00
Prev. Close: 1,310.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FD acquires ActivateClients Limited

24 Mar 2015 07:00

RNS Number : 2534I
First Derivatives PLC
24 March 2015
 



24 March 2015

 

First Derivatives PLC

("FD" or the "Company")

 

FD acquires ActivateClients Limited for software development and mobile technology capabilities

 

FD (AIM:FDP.L, ESM:FDP.I), a leading provider of software and consulting services, announces it has acquired the entire issued share capital of ActivateClients Limited ("ActivateClients"). The earnings enhancing acquisition provides complementary software products, particularly HTML5 capabilities, that are expected to enhance the Company's software platform.

 

The vendors of ActivateClients include Pat Brazel and Keith MacDonald, who are Non-Executive Directors of FD. Following the acquisition Mr Brazel, who is Chief Executive Officer of ActivateClients, has been appointed Global Head of Software Sales for FD and will step down from the Board of the Company, as detailed in a separate announcement today.

 

Acquisition rationale

ActivateClients, based in Dublin, Ireland, is a software business targeting financial markets and specialising in delivering applications and trading systems that increase customer engagement for its clients. It uses agile software development methods and delivers solutions either on premise or through a Software as a Service model. Its HTML5 capabilities are particularly attractive to FD and the Company intends to accelerate its product development roadmap through wider use of HTML5 following this acquisition.

 

ActivateClients operates for clients across the broking, institutional foreign exchange and fixed income markets. In addition ActivateClients has formed three joint ventures; ActivateAlpha, a provider of quantitative analysis software to fund and wealth managers; Active Tradercast, a web-based system to link retail traders and provide research and analysis; and Enhanced Bond Analytics, a proprietary software system designed to identify arbitrage opportunities in G7 sovereign debt markets.

 

Pat Brazel, Chief Executive Officer of ActivateClients, commented: "ActivateClients' achievement has been built on the technical expertise and dedication of our team and I am sure that our products and front office development capabilities will be a significant asset to FD. We look forward to working with our new colleagues and being part of the continuing FD success."

 

Terms of the Acquisition

The initial consideration for the acquisition is €4.75m (£3.4m), of which €1.5m (£1.1m) is payable in cash and €3.25m (£2.4m) is payable through the issue of 183,185 FD new ordinary shares (the "Consideration Shares"). Deferred consideration of up to €2.0m (£1.4m) is payable on the achievement of agreed targets in the year to 29 February 2016. In its latest financial year to 31 December 2014, ActivateClients reported revenues of €1.0m and €0.2m of profit before tax.

 

Mr Brazel will receive 97,417 Consideration Shares. He does not currently hold any FD ordinary shares and following the acquisition he will hold 0.4 per cent of the enlarged issued capital. Mr MacDonald will receive 35,877 Consideration Shares following which he will hold 45,877 FD ordinary shares representing 0.2 per cent of the enlarged issued share capital.

 

Application has been made for the 183,185 Consideration Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 27 March 2015. The Consideration Shareswill rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 23,165,961 ordinary shares.

 

Brian Conlon, Chief Executive Officer of FD, commented: "ActivateClients is a low-risk, earnings-enhancing acquisition for the Company that will deliver synergies on a number of levels. It provides additional technology capabilities, particularly in HTML5, and its staff possess software development skills that will be useful across a range of projects FD is working on. We welcome its staff to the Company."

 

Enquiries:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Charles Stanley Securities

(Nominated Adviser and Broker)

Russell Cook

Carl Holmes

+44 (0)20 7149 6000

Goodbody Corporate Finance(ESM Adviser and Broker)

Linda Hickey

+353 1 667 0420

Walbrook PR

Paul Cornelius

Nick Rome

Sam Allen

+44 (0)20 7933 8780

 

 

About First Derivatives

FD is a global technology provider with nearly 20 years of experience of working with some of the world's largest finance, technology and energy institutions. It holds a 65% stake in Palo Alto-based Kx Systems, developer of the world-leading database technology, kdb+. It employs over 1,200 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry. For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQPKQDKDBKKNNB
Date   Source Headline
30th May 20175:12 pmRNSDirector/PDMR Shareholding
30th May 20172:06 pmRNSIssue of Equity from exercise of Share Options
16th May 20177:00 amRNSFinal Results
15th May 20175:09 pmRNSAppointment and Directorate Change
24th Apr 20177:00 amRNSTrading Update and Notice of Results
3rd Apr 201710:28 amRNSTotal Voting Rights
20th Mar 20177:00 amRNSEnterprise Securities Market Notice
14th Mar 20174:39 pmRNSIssue of Equity
14th Mar 20177:00 amRNSCollaboration Agreement with Airbus
2nd Mar 20177:00 amRNSContract Win
28th Feb 201710:09 amRNSTotal Voting Rights
7th Feb 20177:00 amRNSEnterprise Securities Market Notice
1st Feb 20173:54 pmRNSIssue of Equity
30th Dec 201610:57 amRNSTotal Voting Rights
23rd Dec 20167:00 amRNSEnterprise Securities Market Notice
19th Dec 20164:06 pmRNSIssue of Equity
7th Dec 20161:26 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSEnterprise Securities Market Notice
1st Dec 20164:52 pmRNSIssue of Equity from exercise of Share Options
30th Nov 201612:21 pmRNSTotal Voting Rights
8th Nov 20167:00 amRNSEntry into Retail Analytics market
8th Nov 20167:00 amRNSEnterprise Securities Market Notice
3rd Nov 20164:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:20 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:19 pmRNSDirector/PDMR Shareholding
1st Nov 20166:13 pmRNSIssue of Equity
1st Nov 20167:00 amRNSHalf Yearly Report
19th Oct 20167:00 amRNSNotice of Interim Results
30th Sep 20169:53 amRNSTotal Voting Rights
14th Sep 20167:00 amRNSEnterprise Securities Market Notice
7th Sep 20162:15 pmRNSIssue of Equity from exercise of Share Options
29th Jul 20161:29 pmRNSTotal Voting Rights
20th Jul 20164:59 pmRNSDirector Shareholding - AMENDMENT
19th Jul 20165:03 pmRNSDirector Shareholding
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
30th Jun 20168:05 amRNSTotal Voting Rights
23rd Jun 20162:06 pmRNSResult of AGM
15th Jun 20167:00 amRNSDirector/PDMR Shareholding
6th Jun 201612:00 pmRNSIssue of Equity from exercise of Share Options
3rd Jun 20163:45 pmRNSAnnual Report 2015/16 and AGM Notice
19th May 20165:11 pmRNSHolding(s) in Company
17th May 20167:00 amRNSFinal Results
13th May 20164:38 pmRNSDirectorate Change
27th Apr 20167:00 amRNSStrategic Partnership with Thomson Reuters
26th Apr 20167:00 amRNSNotice of Results
4th Apr 20167:00 amRNSTrading Update
31st Mar 20164:44 pmRNSTotal Voting Rights
7th Mar 20167:00 amRNSEnterprise Securities Market Notice
1st Mar 20164:14 pmRNSIssue of Equity
29th Jan 20169:46 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.